Please note: Merz Therapeutics GmbH assumes no responsibility for the content of the following website or any links to other pages. We have no influence over the information provided there.
If you come across any illegal content, please inform us immediately.
Hepa- Merz®Granules Active substance: L-ornithine- L-aspartate Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose,
For risks and side effects please read package insert and ask your doctor or pharmacist.
Version July 2019
Merz Pharmaceuticals GmbH, 60048 Frankfurt
LATAM:
Hepa- Merz®Granules Active substance: L-ornithine- L-aspartate Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose, aspartame.
For risks and side effects please read package insert and ask your doctor or pharmacist.